Concepcion
Concepcion Abellas Alvarez, Vigo ES
Patent application number | Description | Published |
---|---|---|
20140077967 | WIRELESS PATIENT MONITORING SYSTEM - Disclosed embodiments include a wireless portable medical monitoring apparatus that includes (a) a hospital bed or medical stretcher; (b) a plurality of wireless biomedical sensors attached to the hospital bed or medical stretcher; and (c) a communications module configured for wirelessly transmitting jointly compressed biomedical signals. The communication module is configured to transmit signals as a block of coherent data. Additionally, the communication module includes fast-joint coding and decoding, transmission error correction, and information exchange between different layers to optimize network throughput. | 03-20-2014 |
Concepcion Aguayo Ferrer, Madrid ES
Patent application number | Description | Published |
---|---|---|
20110123497 | GRAFT COMPOSITION FOR NEURAL TISSUE REGENERATION, METHOD OF PRODUCTION AND USES THEREOF - The present invention provides a biocompatible, biodegradable graft composition for regeneration of neural tissue, comprising the following components: a) a gel scaffold formed from an isolated platelet containing fluid and an activating agent comprising calcium chloride, with or without thrombin, b) a nerve growth factor selected from BDNF, NGF, retinoic acid and combinations thereof, and c) a culture of at least 50,000 progenitor stem cells; the method of production and the uses thereof. | 05-26-2011 |
Concepcion Gonzalez Gonzalez, Cornella ES
Patent application number | Description | Published |
---|---|---|
20090012307 | Process for the Preparation of 4-(imidazol-1-yl)benzenesulfonamide Derivatives - Process for the preparation of 4-(imidazol-1-yl)benzenesulfonamide derivatives of formula I, wherein R | 01-08-2009 |
Concepcion Pedregal Tercero, Alcobendas ES
Patent application number | Description | Published |
---|---|---|
20120214784 | SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS - An ORL-1 receptor antagonist of the formula: its uses, and methods for its preparation are described. ORL-1 antagonists are deemed to be useful in the treatment of depression and/or the treatment of overweight, obesity, and/or weight maintenance post treatment for overweight or obesity. Certain compounds have also demonstrated through animal models that the compounds of the present invention are useful for the treatment of migraines. | 08-23-2012 |
Concepcion Pedregal-Tercero, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100113579 | PRODRUGS OF EXCITATORY AMINO ACIDS - This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders. | 05-06-2010 |
20110118251 | SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS - An ORL-1 receptor antagonist of the formula: | 05-19-2011 |
20110207672 | METHODS OF TREATMENT USING A PRODRUG OF AN EXCITATORY AMINO ACID - This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders. | 08-25-2011 |
20120172422 | Methods of Treatment Using a Prodrug of an Excitatory Amino Acid - This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders. | 07-05-2012 |
Concepcion Perez Martin, Madrid ES
Patent application number | Description | Published |
---|---|---|
20150057311 | Heterocyclic GSK-3 Allosteric Modulators - The present invention relates to heterocyclic substituted quinoline derivatives as allosteric inhibitors of the glycogen synthase kinase-3 (GSK-3) enzyme. Therefore, these compounds are useful for the manufacturing of a medicament designed for the treatment and/or prevention of diseases wherein GSK-3 is involved, such as neurodegenerative diseases, inflammatory diseases, cancer, diabetes, and to promote various regenerative processes. | 02-26-2015 |
Concepción Nieto Magro, Alcobendas-Madrid ES
Patent application number | Description | Published |
---|---|---|
20110183950 | TREATMENT OF VAGINAL ATROPHY IN WOMEN WITH TUMOR PATHOLOGY RISK - The present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal administration with the capacity to self-limit the absorption of estriol, for the prevention and/or the treatment of urogenital atrophy in women, said women having a high probability of developing an estrogen-dependent tumor or suffering or having suffered from an estrogen-dependent tumor. | 07-28-2011 |
Concepción Perez Martín, Madrid ES
Patent application number | Description | Published |
---|---|---|
20120225879 | SUBSTITUTED 5-IMINO-1,2,4-THIADIAZOLES THAT CAN BE USED TO TREAT NEURODEGENERATIVE DISEASES - The present invention is based on the use of a broad family of 5-imino-1,2,4-thiadiazoles as potential new drugs for the treatment of diseases in which PDE7 inhibition is important, specially inflammatory diseases, autoimmune and neurodegenerative disorders. On the other hand, compounds of the 5-imino-1,2,4-thiadiazole family are here described, as well as their synthetic procedures, and they may have great application as drug or drug candidates. | 09-06-2012 |
Concepción Pérez Martín, Madrid ES
Patent application number | Description | Published |
---|---|---|
20120129877 | USE OF QUINAZOLINE DERIVATIVES FOR NEURODEGENERATIVE DISEASES - The present invention relates to the use of a series of quinazoline-derived compounds to produce a medicament for the treatment and/or prevention of neurological and/or neurodegenerative diseases, such as Parkinson's disease or Alzheimer's disease. The present invention also relates to a method for the treatment and/prevention of neurological and/neurodegenerative diseases comprising the administration of a therapeutically effective amount of said compounds. | 05-24-2012 |
Concepción PÉrez MartÍnez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20150352082 | SUBSTITUTED BENZOTHIAZOLES AND THERAPEUTIC USES THEREOF FOR THE TREATMENT OF HUMAN DISEASES - The invention relates to a family of differently substituted benzothiazoles having inhibitory activity against casein kinase 1 (CK-1) enzyme, as a result of which they are suitable for use in the treatment or prevention of diseases caused by this enzyme, particularly diseases associated with circadian rhythm and inflammatory, autoimmune, psychiatric, neurodegenerative, neurological or ophthalmic diseases, as well as for inducing cell regeneration | 12-10-2015 |
Concepción Soto Soriano, Valencia ES
Patent application number | Description | Published |
---|---|---|
20120178730 | SOD-IMITATING METAL COMPLEXES - The present invention comprises a process to synthesise metal complexes from macrocyclic polyazapyridinophane compounds characterised as superoxide dismutase enzyme (SOD) mimetics. Furthermore, the present invention relates to the macrocyclic polyazapyridinophane compounds themselves, the metal complexes formed from these and to their use in the treatment of diseases the aetiology of which is based on disturbances in the activity of, or a deficiency in endogenous SOD, mainly as anti-inflammatories, analgesics and antioxidant compounds providing protection against cellular oxidative stress. | 07-12-2012 |